ProfileGDS4718 / 211039_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 26% 24% 32% 33% 34% 28% 26% 26% 25% 30% 25% 32% 33% 23% 24% 25% 25% 27% 33% 25% 28% 30% 21% 22% 33% 25% 24% 23% 24% 26% 28% 25% 30% 20% 28% 22% 32% 28% 27% 22% 24% 31% 28% 28% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]4.3939426
GSM549102patient 115, normal, homogenized [OPG study]4.3194224
GSM549104patient 119, normal, homogenized [OPG study]4.5933232
GSM549108patient 138, normal, homogenized [OPG study]4.7274633
GSM549119patient 077, normal, homogenized [OPG study]4.7437134
GSM549133patient 032, cancer, homogenized [OPG study]4.3888928
GSM549139patient 042, cancer, homogenized [OPG study]4.3685926
GSM549099patient 107, normal, homogenized [OPG study]4.4153626
GSM549109patient 139, normal, homogenized [OPG study]4.3703925
GSM549110patient 046, normal, homogenized [OPG study]4.5407430
GSM549114patient 063, normal, homogenized [OPG study]4.3137625
GSM549122patient 082, normal, homogenized [OPG study]4.6216432
GSM549134patient 033, cancer, homogenized [OPG study]4.6606933
GSM549136patient 036, cancer, homogenized [OPG study]4.2138823
GSM549140patient 044, cancer, homogenized [OPG study]4.2441524
GSM549111patient 047, normal, homogenized [OPG study]4.3118125
GSM549113patient 057, normal, homogenized [OPG study]4.2901725
GSM549132patient 031, cancer, homogenized [OPG study]4.393727
GSM549137patient 038, cancer, homogenized [OPG study]4.6393833
GSM549142patient 047, cancer, homogenized [OPG study]4.4262625
GSM549100patient 110, normal, homogenized [OPG study]4.4595228
GSM549107patient 135, normal, homogenized [OPG study]4.5168530
GSM549115patient 068, normal, homogenized [OPG study]4.1269321
GSM549116patient 072, normal, homogenized [OPG study]4.1999822
GSM549120patient 078, normal, homogenized [OPG study]4.6718833
GSM549131patient 030, cancer, homogenized [OPG study]4.2840625
GSM549118patient 074, normal, homogenized [OPG study]4.2967724
GSM549129patient 027, cancer, homogenized [OPG study]4.27523
GSM549123patient 088, normal, homogenized [OPG study]4.2954224
GSM549124patient 006, cancer, homogenized [OPG study]4.435926
GSM549126patient 015, cancer, homogenized [OPG study]4.4414828
GSM549128patient 025, cancer, homogenized [OPG study]4.3037225
GSM549103patient 117, normal, homogenized [OPG study]4.5947630
GSM549117patient 073, normal, homogenized [OPG study]4.1174920
GSM549138patient 041, cancer, homogenized [OPG study]4.420328
GSM549141patient 045, cancer, homogenized [OPG study]4.1801622
GSM549130patient 028, cancer, homogenized [OPG study]4.6632232
GSM549101patient 111, normal, homogenized [OPG study]4.4596228
GSM549105patient 128, normal, homogenized [OPG study]4.4596227
GSM549106patient 134, normal, homogenized [OPG study]4.1790922
GSM549112patient 048, normal, homogenized [OPG study]4.2954624
GSM549125patient 011, cancer, homogenized [OPG study]4.5970631
GSM549127patient 024, cancer, homogenized [OPG study]4.4391528
GSM549135patient 035, cancer, homogenized [OPG study]4.4029428